6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al.|The Lancet|2018Cited by 372
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trialKi Hong Choi, Joo-Yong Hahn, Yong Hwan Park et al.|The Lancet|2025Cited by 86
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trialJi Woong Roh, Young Bin Song, Joo‐Yong Hahn et al.|Cardiology Journal|2021Cited by 23
Gender differences in the presentation of chest pain in obstructive coronary artery disease: results from the Korean Women’s Chest Pain RegistryDong-Hyuk Cho, Wan Joo Shim, Jimi Choi et al.|The Korean Journal of Internal Medicine|2019Cited by 18
Effects of multiparity on left ventricular diastolic dysfunction in women: cross-sectional study of the KoRean wOmen’S chest pain rEgistry (KoROSE)Hyun‐Jin Kim, Jin‐Ok Jeong, Gil Ja Shin et al.|BMJ Open|2018Cited by 16